Figure 5: Discontinuation rate of non-pegylated IFN (IFN) and pegylated IFN (peg-IFN) therapy (for all patients while on study).
A: in ET
B: in PV
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.